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Abstract: QueF enzymes catalyze the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent
reduction of the nitrile group of 7-cyano-7-deazaguanine (preQ0 ) to 7-aminomethyl-7-deazaguanine
(preQ1 ) in the biosynthetic pathway to the tRNA modified nucleoside queuosine. The QueF-catalyzed
reaction includes formation of a covalent thioimide intermediate with a conserved active site
cysteine that is prone to oxidation in vivo. Here, we report the crystal structure of a mutant of
Bacillus subtilis QueF, which reveals an unanticipated intramolecular disulfide formed between the
catalytic Cys55 and a conserved Cys99 located near the active site. This structure is more symmetric
than the substrate-bound structure and exhibits major rearrangement of the loops responsible for
substrate binding. Mutation of Cys99 to Ala/Ser does not compromise enzyme activity, indicating
that the disulfide does not play a catalytic role. Peroxide-induced inactivation of the wild-type
enzyme is reversible with thioredoxin, while such inactivation of the Cys99Ala/Ser mutants is
irreversible, consistent with protection of Cys55 from irreversible oxidation by disulfide formation
with Cys99. Conservation of the cysteine pair, and the reported in vivo interaction of QueF with the
thioredoxin-like hydroperoxide reductase AhpC in Escherichia coli suggest that regulation by the
thioredoxin disulfide-thiol exchange system may constitute a general mechanism for protection of
QueF from oxidative stress in vivo.
Keywords: tRNA modification; oxidoreductase; tunneling fold

1. Introduction
QueF is the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent nitrile reductase
that functions in the biosynthetic pathway of the tRNA-modified nucleoside queuosine (Q, [1]),
a 7-deazaguanosine nucleoside found at the wobble position of bacterial and eukaryotic tRNAs
possessing the GUN anticodon (those encoding for Tyr, His, Asp and Asn) [2]. QueF catalyzes
the NADPH-dependent 4-electron reduction of the nitrile group of the pathway intermediate
7-cyano-7-deazaguanine (preQ0 ) to 7-aminomethyl-7-deazaguanine (preQ1 ), the last intermediate
in the tRNA-independent portion of the pathway [1] (Figure 1). PreQ1 is subsequently inserted into
the tRNA by the enzyme tRNA-guanine transglycosylase [3], and the remainder of the pathway occurs
on the tRNA [4,5]. Although Q is essential for translational fidelity and efficiency in both Bacteria
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by B. subtilis QueF, is comprised of proteins that are constructed from subunits possessing a single
T-fold domain, whereas the bimodular subfamily—e.g., V. cholerae and E. coli QueF—is comprised
of proteins that are constructed from subunits possessing two weakly homologous tandem T-fold
domains [1]. B. subtilis QueF, a ~160 amino acid protein with a single T-fold domain, is a homodecamer
of two head-to-head facing pentamers, each composed of a cyclic arrangement of monomeric T-fold
Biomolecules 2016, 6, 30
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The catalytic cysteine of QueF has been shown to be prone to oxidation in vivo in the proteomes
of several Bacillus species when exposed to oxidative stress from sodium hypochlorite [20]. It has
also been shown that QueF interacts in vivo with the thioredoxin-like alkyl hydroperoxide reductase
AhpC in E. coli, suggesting that the enzyme may be regulated by the thioredoxin disulfide-thiol
exchange system [21]. Here, we present crystallographic and biochemical evidence that B. subtilis
QueF is protected from irreversible oxidation by a conserved intramolecular disulfide between the
catalytic Cys55 and a second cysteine (Cys99) located in a helix lining the active site, and that oxidative
inactivation of the enzyme is reversible with thioredoxin. Bioinformatic and phylogenetic analyses
of the two QueF subfamilies reveal a conservation pattern of the disulfide that is consistent with a
biological role in adaptation to oxidative stress environments.
2. Results and Discussion
2.1. Activity of B. subtilis QueF Mutants
Both of the Cys99 mutants exhibited robust activity (Table 1), while the Glu97Gln mutant
displayed low, but measurable, activity (~2% of wild-type). Given the significantly decreased activity
of this mutant, we carried out a full steady-state analysis to determine the kinetic constants, which
revealed a KM (preQ0 ) = 67 µM and kcat = 0.036/min. For comparison, the wild-type enzyme exhibits a
KM (preQ0 ) = 0.237 µM and kcat = 0.66/min [11]. The much larger impact on KM (280-fold) as compared
to kcat (18-fold) is consistent with the putative role of Glu97 in substrate binding [1,16].
Table 1. Relative catalytic activity of wild-type and mutant QueF enzymes.
Enzyme

Relative Activity 1 (%)

Wild-type QueF
Cys99Ala
Cys99Ser
Glu97Gln

100 ± 4
80 ± 4
74 ± 3
1.9 ± 0.1

1

Relative activity reflects the average initial velocities for each enzyme (determined via ultraviolet-visible
spectrophotometry time course assays) divided by the average initial velocity for the wild-type enzyme. Standard
errors for the initial velocity measurements of specific enzymes ranged from 3% to 4.5%.

2.2. Formation of an Active-Site Disulfide in a Substrate-Free Mutant of B. subtilis QueF
The Glu97Gln mutant enzyme crystallized in the same space group (P32 21) as previously
determined for the wild-type enzyme and the Cys55Ala mutant, both bound to preQ0 [16]. The
refined structure contains five subunits (A–E) in the crystallographic asymmetric unit and exhibits
good geometry and an R factor below 0.2 (Table 2). The overall structure shows a homodecamer
formed by two pentameric subunits organized in a face-to-face manner through coordination of the
C-terminal tails via divalent metal ions, similar to the preQ0 -bound structures. However, the Glu97Gln
mutant structure is substantially more symmetric, and represents the substrate- and cofactor-free
form of the enzyme (here referred to as the apo form) as no difference electron density corresponding
to the substrate, cofactor or the product is seen in any of the ten active sites in the homodecamer.
Superposition of the Glu97Gln mutant structure with any of the preQ0 -bound structures (wild-type
or Cys55Ala) reveals significant tightening of the homodecamer in the apo form relative to the
preQ0 -bound form (Figure 4). Successive counterclockwise shifts in the positions of the subunits
manifests as a net rotation of subunit E by 25◦ around the tunnel five-fold axis and translation of its
center of mass along the axis by 17 Å relative to its position in the preQ0 -bound structures. The most
striking difference is the formation of a disulfide bridge in all the active sites between the catalytic
Cys55 and Cys99 located in the N-terminal turn of the second helix of the tunnel fold, the helix
lining the inter-subunit interface (Figure 5). Disulfide formation is accompanied by full unwinding
of the N-terminal turn of the helix, indicating conformational flexibility of the active sites. These
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disulfides are apparently very stable, given that reducing agents were included in the purification and
fold, thebuffers.
helix lining the inter‐subunit interface (Figure 5). Disulfide formation is accompanied by full
crystallization
unwinding of the N‐terminal turn of the helix, indicating conformational flexibility of the active sites.
These disulfides are apparently very stable, given that reducing agents were included in the
Table 2. X-ray data collection parameters and structure refinement statistics.
purification and crystallization buffers.
DataTable
Collection:
2. X‐ray data collection parameters andValue
structure refinement statistics.
Space group
Data collection:
Unit cell (Å)
Space group
Wavelength (Å)
Unit cell (Å)
Resolution range (Å)
Wavelength (Å)
Completeness (%)
Resolution range (Å)
Redundancy
Completeness (%)
Rmerge , Rpim (%) 2
Redundancy
<I/σ(I)>
2
Rmerge, Rpim (%)

Refinement:
<I/σ(I)>
Number of reflections
Refinement:
Working/free Number of reflections
Number of atomsWorking/free
Number of atoms
Total
Total
Water/Mg2+
Water/Mg2+
PEG
R-cryst 3 /R-free 4R‐cryst
(%) 3/R‐free 4 (%)
Rmsd bond lengths
(Å)bond lengths (Å)
Rmsd
Rmsd bond angles
(◦ ) bond angles (°)
Rmsd
Wilson B-factor (Å2)
Wilson B‐factor (Å2)

PEG

Average B-factor Average B‐factor
Protein
Protein
Metals
Metals

P32 21

Value
87.31, 87.31, 196.73
P3221
1.12709
87.31, 87.31, 196.73
50–2.5 (2.54–2.50) 1
1.12709
98.0 (92.5) 1
50–2.5 (2.54–2.50)
5.0 (3.0)
98.0 (92.5)
0.087, 0.060 (0.630, 0.627)
5.0 (3.0)
13.10 (1.17)
0.087, 0.060 (0.630, 0.627)
13.10 (1.17)

28,753/1466 (1937/109)
28,753/1466 (1937/109)

6417
6417 285/7
285/7
37
37
0.189/0.257
(0.303/0.409)
0.189/0.257
(0.303/0.409)
0.019 0.019
2.007 2.007
50.2 50.2
45.5 45.5
79.7 79.7
46.76 46.76

Water
Ramachandran Plot (%)
Ramachandran Plot
(%)
Favored
94.0
Favored
94.0
Allowed
4.5 5
5

Water

1

Allowed

4.5

Highest‐resolution shell information in parentheses; 2 Rmerge = Σ|Iobs − <I>|/ΣIobs, Rpim = (Σh [1/(nh −

1/2
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polyethylene glycol.

Figure 4. Superposition of the crystal structures of the substrate-free Glu97Gln mutant of B. subtilis
QueF (colors) with the substrate-bound wild-type enzyme as a thioimide intermediate (grey) generated
by optimizing alignment of subunits A from both structures. Successive shifts in the positions of
subunits B–E result in tightening of the decamer in a counterclockwise screw fashion indicated by the
arrow. For clarity, only one pentamer is shown. Bound preQ0 molecules in the wild-type structure are
shown in red.

Figure 4. Superposition of the crystal structures of the substrate‐free Glu97Gln mutant of B. subtilis
QueF (colors) with the substrate‐bound wild‐type enzyme as a thioimide intermediate (grey)
generated by optimizing alignment of subunits A from both structures. Successive shifts in the
positions of subunits B–E result in tightening of the decamer in a counterclockwise screw fashion
indicated
the arrow. For clarity, only one pentamer is shown. Bound preQ0 molecules in the wild‐6 of 13
Biomolecules
2017, by
7, 30
type structure are shown in red.
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.
We
analyzed
the
disulfide
bond
geometries
in
the
QueF
Glu97Gln
mutant
structure
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analyzed
the
disulfide
bond
geometries
in
the
QueF
Glu97Gln
mutant
structure
using
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γ
β
using
the Disulfide
Bond Dihedral
Angle Energy
(http://services.mbi.ucla.edu/disulfide/).
Disulfide
Bond Dihedral
Angle Energy
ServerServer
(http://services.mbi.ucla.edu/disulfide/).
All of All
the
of the disulfides in the protein decamer exhibit dihedral angles with the signs −,−,−,+,− for χ1 , χ2 , χ3 ,
χ2 0 , χ1 0 , respectively (Table 3), indicating a minus left-handed hook (–LHHook) geometry characteristic
of regulatory disulfides [24]. These angles and the calculated disulfide strain energy of ~13–19 kJ/mol
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Disulfide Strain
Subunit χ1 (°)
χ2 (°)
χ3 (°)
Bond Length (Å)
χ2′ (°) χ1′ (°)
Energy
(kJ/mol)
Disulfide
Strain
Bond Length
χ2 0 (◦ )
χ1 0 (◦ )
Subunit
χ1 (◦ )
χ2 (◦ )
χ3 (◦ )
Energy
(kJ/mol)
(Å)
A
−59.85
−126.76
−105.12
2.03
176.01
−66.90
15.023
BA
−56.90
2.03
171.20
16.120
−59.85 −123.68
−126.76−89.05
−105.12
2.03
176.01 −81.83
−66.90
15.023
CB
−59.70
2.05
168.10
14.772
−89.05
2.03
171.20 −63.57
−81.83
16.120
−56.90 −116.71
−123.68−102.91
DC
−60.93
2.07
173.65
18.584
−59.70 −127.32
−116.71−79.75
−102.91
2.05
168.10 −89.46
−63.57
14.772
ED
−55.16
2.04
172.66
13.938
−60.93 −120.73
−127.32−94.72
−79.75
2.07
173.65 −72.34
−89.46
18.584
E
−55.16 −120.73 −94.72
2.04
172.66
−72.34
13.938
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oxidative stress imposed by the host immune response is high. For example, upon inspecting QueF
sequences
from 164 human and plant bacterial pathogens, only seven sequences lack Cys99/Cys236,
sequences from 164 human and plant bacterial pathogens, only seven sequences lack Cys99/Cys236,
and six of them harbor the potential alternative Cys53 (Supplementary Table S1). Conversely, when
considering a sample of 333 QueF sequences that lack Cys99 and any alternative backdoor cysteine,
all but five are from non‐pathogens. Lastly, the strict conservation of Cys236 in bimodular QueF is
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and six of them harbor the potential alternative Cys53 (Supplementary Table S1). Conversely, when
considering a sample of 333 QueF sequences that lack Cys99 and any alternative backdoor cysteine,
all but five are from non-pathogens. Lastly, the strict conservation of Cys236 in bimodular QueF is
consistent with the prevalence of the bimodular QueF subfamily in pathogenic bacteria (Supplementary
Table S1).
3. Materials and Methods
3.1. Mutagenesis of QueF
Mutagenesis was carried out with the QuikChange XL (Stratagene, La Jolla, CA, USA) or
QuikChange II (Agilent, Santa Clara, CA, USA) kits. The sequences of the primers used for the
construction of the mutant plasmids were as follows:
E97Q(sense)
5’-GTTCATGATGATATTCATGCAGTCCTTGTGGAAGTCAC-3’
E97Q(antisense)
5’-GGTGACTTCCACCAGGACTGCATGAATATCATCATGAACG-3’
C99S(sense)
5’-GGTGACTTCCACGAGGACAGCATGAATATCATCATGAACG-3’
C99S(antisense)
5’- CGTTCATGATGATATTCATGCTGTCCTCGTGGAAGTCACC-3’
C99A(sense)
5’-GGTGACTTCCACGAGGACGCCATGAATATCATCATGAACG-3’
C99A(antisense)
5’- CGTTCATGATGATATTCATGGCGTCCTCGTGGAAGTCACC-3’.
The queF gene in the pET-30Xa vector [1] was used as a template to generate the single mutants.
The PCR protocol consisted of an initial hold at 94 ◦ C for 45 s, followed by 18 cycles of 94 ◦ C for 45 s,
55 ◦ C for 60 s, and 68 ◦ C for 8 min. After 18 cycles, the reaction mixtures were kept at 4 ◦ C. Dpn1 (1 µL,
10 U/µL, Fermentas) was added and the reaction mixture was incubated at 37 ◦ C for 1 h before the
plasmid was transformed into ultracompetent E. coli (DH5α) cells. Single colonies grown overnight
on kanamycin containing (30 µg·mL−1 ) agar plates were selected and cultured in 3 mL Luria-Bertani
media containing 30 µg·mL−1 for 7 h. The plasmid DNA was purified using the Qiagen miniprep kit
(Qiagen, Germantown, MD, USA), and the mutated genes sequenced to verify the mutation and the
otherwise unaltered DNA sequence. For protein expression, the mutant plasmids were transformed
into the E. coli BL21(DE3) cell line. The expression and purification of the QueF mutant proteins were
carried out as previously described for the wild-type protein [11,26].
3.2. Activity Assays of Glu97Gln and Cys99Ala/Ser Mutants
Standard assays for measuring the enzymatic activity of wild-type and mutant QueF enzymes
followed the oxidation of NADPH by ultraviolet-visible spectrophotometry (UV-Vis) as described
previously [11]. For determining the kinetic parameters of the Glu97Gln mutant, the fluorescence
assay based on the decomposition of product NADP+ was employed as previously described [11].
3.3. Crystallization, X-ray Data Collection and Crystal Structure Determination
The Glu97Gln QueF mutant was crystallized in the absence of preQ0 using the vapor diffusion
method at 293.15 K. Briefly, a sample containing 4 mg/mL protein, in 50 mM Tris pH 7.5, 50 mM KCl,
1 mM MgCl2 and 1 mM β-mercaptoethanol (BME) was prepared. Hanging drops were setup by mixing
equal volumes of sample and reservoir solution containing 19% polyethylene glycol monomethyl
ether 550, 43 mM imidazole-Cl (pH 6.8), 53 mM imidazole (pH 8.2), 30 mM CaCl2 , and 4% dimethyl

Biomolecules 2017, 7, 30

10 of 13

sulfoxide. Rhomb shaped crystals appeared in two days and were harvested and flash frozen in liquid
nitrogen without use of additional cryoprotectant. The X-ray data were collected using synchrotron
radiation at the Stanford Synchrotron Radiation Lightsource, beamlines 7-1. The data were processed
using HKL2000 [27]. The structure was determined using the molecular replacement Bayesian protocol
in the Phaser crystallographic software (version 2.7.17) [28] and using the structure of a single B. subtilis
QueF monomer (from PDB ID 4FGC) as a search model. The presence of the disulfide in the structure
was confirmed by difference Fourier methods using model phases with Cys55 and Cys99 deleted
from the model (omit map). The structure was refined using Refmac (version 5.8.0135) [29] and Coot
(version 0.8.2) [30]. The X-ray data and 3D coordinates have been deposited in the PDB under accession
ID 5UDG.
3.4. Sequence Analysis
A BLASTp search of the NCBI protein database, conducted using the sequence of B. subtilis
QueF, yielded a non-redundant set of ~3500 sequences. The sequences were aligned using the
Multiple Alignment Using Fast Fourier Transform (MAFFT) program within the Jalview software [31].
Sequences were checked for the simultaneous presence of the active site residues defining the QueF
family. These features include Cys55/194 (B. subtilis residue numbers/V. cholerae residue numbers),
Asp62/201, Glu97/234, and the QueF motif including Glu78/94 [1,16]. Sequences lacking any of
these features were considered non-QueF and were excluded from the analysis. The sequences
were divided into the two subfamilies, unimodular (<200 residues with a single T-fold domain) and
bimodular (>200 residues with tandem T-folds) and further examined for the presence of Cys99/236.
For sequences lacking Cys99/236, 3D homology models were produced using Phyre2 (version 2.0) [32]
and inspected for the presence of alternative cysteine residues in the active site region. Phylogenetic
analysis was conducted in the program TOPALi (version 2.5) [33] and the phylogenetic tree was
calculated using MrBayes (version 3.2) [34].
3.5. H2 O2 Oxidation of Wild-Type QueF and Cys99Ala/Ser Mutants
A 120 µL stock QueF solution containing 100 mM phosphate (pH 6.5), 50 mM KCl, 20 mM
MgCl2 , and 36 µM protein was prepared, and a 20 µL aliquot was removed. To the remaining stock
solution was added 5 µL of a solution of 1 mM hydrogen peroxide and this was allowed to react.
At time-points throughout the reaction (15, 30, 45, 60 or 75 s), a 20 µL aliquot was removed from the
reaction and added to a solution (80 µL) containing 12 units of catalase, and 1 mM dithiothreitoland
mixed thoroughly to quickly quench the unreacted hydrogen peroxide. The quenched solution was
then transferred to a microcuvette and preQ0 and NADPH were added to a final concentration of
100 µM and 180 µM, respectively, and the absorbance of the reaction at 340 nm was monitored over a
period of 20 min.
3.6. Activity Recovery of Oxidized QueF Enzymes
Wild type and Cys99Ala/Ser mutant enzymes of QueF were oxidized with H2 O2 for 45 s under
the conditions described above. The oxidation reactions were then quenched with a solution containing
12 units of catalase and 5 equivalents of thioredoxin. At time-points throughout the reaction (10, 20,
and 30 min), a 20 µL aliquot of the solution was transferred to a microcuvette containing 100 µM preQ0
and 180 µM NADPH. The absorbance at 340 nm was monitored over a period of 20 min to determine
the initial velocity. To ensure accurate measurement of recovered activity, a control experiment was
performed in which the activity of each enzyme was measured after oxidation as described above to
ensure that each had been rendered inactive prior to treatment with thioredoxin.
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4. Conclusions
QueF is protected from irreversible oxidation by a conserved intramolecular disulfide that can
be reduced by thioredoxin, and regulation by the thioredoxin disulfide-thiol exchange system may
constitute a general mechanism for protection of QueF from oxidative stress in vivo.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/7/1/30/s1.
Figure S1: 3D homology model of unimodular QueF, which lacks the disulfide forming Cys99, but contains Cys53
in proximity to the catalytic Cys55 in the active site loop. The model was generated using the Aquifex aeolicus
QueF sequence and the Phyer2 server (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index). Table S1:
Classification of 164 bacterial pathogens based on the subfamily that their QueF proteins belong to and the
presence/absence of the disulfide forming Cys99 (and the homologous Cys236 in bimodular QueF) in the
protein sequence.
Acknowledgments: We thank Ms. S. Thacker and M. Sherani for general lab support. This project was supported
by National Science Foundation grant CHE-1309323 to D. Iwata-Reuyl and M.A. Swairjo, National Institutes of
Health (NIH) grant GM110588 to M.A. Swairjo and D. Iwata-Reuyl, and NIH grant GM70641 to D. Iwata-Reuyl.
Use of the Stanford Synchrotron Radiation Lightsource (SSRL), Stanford Linear Accelerator Center National
Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy
Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported
by the Department of Energy Office of Biological and Environmental Research, by the NIH, and the National
Institute of General Medical Sciences (NIGMS) (including grant P41GM103393). The contents of this publication
are solely the responsibility of the authors and do not necessarily represent the official views of the NIGMS or
the NIH.
Author Contributions: M.A.S. and D.I.-R. conceived and designed the experiments; A.M., A.B.R., B.W.K.L., S.W.C.
and M.K.K. performed the experiments; B.S. analyzed the data; and M.A.S. and D.I.-R. wrote the paper.
Conflicts of Interest: The authors declare no conflict of interest. The founding sponsors had no role in the design
of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the
decision to publish the results.

References
1.

2.

3.

4.

5.
6.
7.
8.
9.

Van Lanen, S.G.; Reader, J.S.; Swairjo, M.A.; de Crecy-Lagard, V.; Lee, B.; Iwata-Reuyl, D. From cyclohydrolase
to oxidoreductase: Discovery of nitrile reductase activity in a common fold. Proc. Natl. Acad. Sci. USA 2005,
102, 4264–4269. [CrossRef] [PubMed]
Harada, F.; Nishimura, S. Possible anticodon sequences of tRNA His, tRNA Asm, and tRNA Asp from
Escherichia coli B. Universal presence of nucleoside Q in the first position of the anticondons of these transfer
ribonucleic acids. Biochemistry 1972, 11, 301–308. [CrossRef] [PubMed]
Noguchi, S.; Nishimura, Y.; Hirota, Y.; Nishimura, S. Isolation and characterization of an Escherichia coli
mutant lacking tRNA-guanine-transglycosylase. Function and biosynthesis of queuosine in tRNA.
J. Biol. Chem. 1982, 257, 6544–6550. [PubMed]
Iwata-Reuyl, D.; de Crécy-Lagard, V. Enzymatic formation of the 7-deazaguanosine hypermodified
nucleosides of tRNA. In DNA and RNA Modification Enzymes: Structure, Mechanism, Function and Evolution;
Grosjean, H., Ed.; Landes Bioscience: New York, NY, USA, 2009; pp. 379–394.
Iwata-Reuyl, D. Biosynthesis of the 7-deazaguanosine hypermodified nucleosides of transfer RNA.
Bioorg. Chem. 2003, 31, 24–43. [CrossRef]
Vinayak, M.; Pathak, C. Queuosine modification of tRNA: Its divergent role in cellular machinery. Biosci. Rep.
2010, 30, 135–148. [CrossRef] [PubMed]
Marks, T.; Farkas, W.R. Effects of a diet deficient in tyrosine and queuine on germfree mice. Biochem. Biophys.
Res. Commun. 1997, 230, 233–237. [CrossRef] [PubMed]
Meier, F.; Suter, B.; Grosjean, H.; Keith, G.; Kubli, E. Queuosine modification of the wobble base in tRNAHis
influences ‘in vivo’ decoding properties. EMBO J. 1985, 4, 823–827. [PubMed]
Rakovich, T.; Boland, C.; Bernstein, I.; Chikwana, V.M.; Iwata-Reuyl, D.; Kelly, V.P. Queuosine deficiency in
eukaryotes compromises tyrosine production through increased tetrahydrobiopterin oxidation. J. Biol. Chem.
2011, 286, 19354–19363. [CrossRef] [PubMed]

Biomolecules 2017, 7, 30

10.
11.
12.

13.

14.

15.
16.
17.

18.

19.
20.

21.

22.
23.
24.
25.

26.

27.
28.
29.

30.

12 of 13

Reader, J.; Metzgar, D.; Schimmel, P.; de Crécy-lagard, V. Identification of four genes necessary for
biosynthesis of the modified nucleoside queuosine. J. Biol. Chem. 2004, 279, 6280–6285. [CrossRef] [PubMed]
Lee, B.W.; Lanen, S.G.; Iwata-Reuyl, D. Mechanistic studies of Bacillus subtilis QueF, the nitrile oxidoreductase
involved in queuosine biosynthesis. Biochemistry 2007, 46, 12844–12854. [CrossRef] [PubMed]
Kim, Y.; Zhou, M.; Moy, S.; Morales, J.; Cunningham, M.A.; Joachimiak, A. High-resolution structure of
the nitrile reductase quef combined with molecular simulations provide insight into enzyme mechanism.
J. Mol. Biol. 2010, 404, 127–137. [CrossRef] [PubMed]
Wilding, B.; Winkler, M.; Petschacher, B.; Kratzer, R.; Glieder, A.; Klempier, N. Nitrile reductase from
Geobacillus kaustophilus: A potential catalyst for a new nitrile biotransformation reaction. Adv. Synth. Catal.
2012, 354, 2191–2198. [CrossRef]
Wilding, B.; Winkler, M.; Petschacher, B.; Kratzer, R.; Egger, S.; Steinkellner, G.; Lyskowski, A.; Nidetzky, B.;
Gruber, K.; Klempier, N. Targeting the substrate binding site of E. Coli nitrile reductase QueF by modeling,
substrate and enzyme engineering. Chemistry 2013, 19, 7007–7012. [CrossRef] [PubMed]
Moeller, K.; Nguyen, G.S.; Hollmann, F.; Hanefeld, U. Expression and characterization of the nitrile reductase
QueF from E. coli. Enzyme Microb. Technol. 2013, 52, 129–133. [CrossRef] [PubMed]
Chikwana, V.M.; Stec, B.; Lee, B.W.; de Crecy-Lagard, V.; Iwata-Reuyl, D.; Swairjo, M.A. Structural basis of
biological nitrile reduction. J. Biol. Chem. 2012, 287, 30560–30570. [CrossRef] [PubMed]
Ribeiro, A.J.M.; Yang, L.; Ramos, M.J.; Fernandes, P.A.; Liang, Z.-X.; Hirao, H. Insight into enzymatic
nitrile reduction: QM/MM study of the catalytic mechanism of QueF nitrile reductase. ACS Catal. 2015, 5,
3740–3751. [CrossRef]
Jung, J.; Czabany, T.; Wilding, B.; Klempier, N.; Nidetzky, B. Kinetic analysis and probing with substrate
analogues of the reaction pathway of the nitrile reductase QueF from Escherichia coli. J. Biol. Chem. 2016, 291,
25411–25426. [CrossRef] [PubMed]
Colloc’h, N.; Poupon, A.; Mornon, J.-P. Sequence and structural features of the T-fold, an original tunneling
building unit. Proteins 2000, 39, 142–154. [CrossRef]
Chi, B.K.; Roberts, A.A.; Huyen, T.T.; Basell, K.; Becher, D.; Albrecht, D.; Hamilton, C.J.; Antelmann, H.
S-bacillithiolation protects conserved and essential proteins against hypochlorite stress in Firmicutes bacteria.
Antioxid. Redox Signal. 2013, 18, 1273–1295. [CrossRef] [PubMed]
Arifuzzaman, M.; Maeda, M.; Itoh, A.; Nishikata, K.; Takita, C.; Saito, R.; Ara, T.; Nakahigashi, K.;
Huang, H.C.; Hirai, A.; et al. Large-scale identification of protein-protein interaction of Escherichia coli
K-12. Genome Res. 2006, 16, 686–691. [CrossRef] [PubMed]
Schmidt, B.; Ho, L.; Hogg, P.J. Allosteric disulfide bonds. Biochemistry 2006, 45, 7429–7433. [CrossRef]
[PubMed]
Hogg, P.J. Disulfide bonds as switches for protein function. Trends Biochem. Sci. 2003, 28, 210–214. [CrossRef]
Cook, K.M.; Hogg, P.J. Post-translational control of protein function by disulfide bond cleavage.
Antioxid. Redox Signal. 2013, 18, 1987–2015. [CrossRef] [PubMed]
Berndt, C.; Lillig, C.H.; Holmgren, A. Thiol-based mechanisms of the thioredoxin and glutaredoxin systems:
Implications for diseases in the cardiovascular system. Am. J. Physiol. Heart Circ. Physiol. 2007, 292,
H1227–H1236. [CrossRef] [PubMed]
Swairjo, M.A.; Reddy, R.P.; Lee, B.; Van Lanen, S.G.; Brown, A.; De Crécy Lagard, V.; Iwata_Reuyl, D.;
Schimmel, P. Crystallization and preliminary X-ray characterization of the nitrile reducatse QueF:
A queuosine biosynthesis enzyme. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 2005, 61, 945–948.
[CrossRef] [PubMed]
Otwinowski, Z.; Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol.
1997, 276, 307–326. [PubMed]
Storoni, L.C.; McCoy, A.J.; Read, R.J. Likelihood-enhanced fast rotation functions. Acta Crystallogr. Sect. D
Biol. Crystallogr. 2004, 60, 432–438. [CrossRef] [PubMed]
Murshudov, G.N.; Vagin, A.A.; Dodson, E.J. Refinement of macromolecular structures by the
maximum-likelihood method. Acta Crystallogr. Sect. D Biol. Crystallogr. 1997, D53, 240–255. [CrossRef]
[PubMed]
Emsley, P.; Cowtan, K. Coot: Model-building tools for molecular graphics. Acta Crystallogr. Sect. D
Biol. Crystallogr. 2004, D60, 2126–2132. [CrossRef] [PubMed]

Biomolecules 2017, 7, 30

31.
32.
33.

34.

13 of 13

Waterhouse, A.M.; Procter, J.B.; Martin, D.M.; Clamp, M.; Barton, G.J. Jalview version 2—A multiple sequence
alignment editor and analysis workbench. Bioinformatics 2009, 25, 1189–1191. [CrossRef] [PubMed]
Kelley, L.A.; Mezulis, S.; Yates, C.M.; Wass, M.N.; Sternberg, M.J.E. The Phyre2 web portal for protein
modeling, prediction and analysis. Nat. Protoc. 2015, 10, 845–858. [CrossRef] [PubMed]
Milne, I.; Lindner, D.; Bayer, M.; Husmeier, D.; McGuire, G.; Marshall, D.F.; Wright, F. TOPALi v2: A rich
graphical interface for evolutionary analyses of multiple alignments on HPC clusters and multi-core desktops.
Bioinformatics 2009, 25, 126–127. [CrossRef] [PubMed]
Ronquist, F.; Huelsenbeck, J.P. MrBayes 3: Bayesian phylogenetic inference under mixed models.
Bioinformatics 2003, 19, 1572–1574. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).

